(DYAX:Consolidated Issue listed on NASDAQ Global Market)
David J. McLachlan
Director, Chairman of Audit Committee and Member of Strategy & Science Committee, Dyax Corp.
|Age||Total Calculated Compensation||This person is connected to 30 board members in 5 different organizations across 7 different industries.|
See Board Relationships
Mr. David J. McLachlan, also known as Dave, has been a Director of Deltagen Inc. since July 22, 2010. Mr. McLachlan has been a Director at Dyax Corp., since May 1999. He serves as a Director at HEARx Ltd; ActivBiotics, Inc. and Benten BioServices, Inc. He has been a Non Employee Director of Skyworks Solutions Inc. since 2000. He served as a Senior Advisor to the Chairman and Chief Executive Officer at Genzyme Corporation from 1999 to 2004. Mr. McLachlan served as Executive ...
55 Network DrivePhone: 617-225-2500
Burlington, Massachusetts 01803
Board Members Memberships*
Director and Chairman of Audit Committee
Lead Independent Director, Chairman of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
Director, Chairman of Audit Committee and Member of Strategy & Science Committee
Former Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Lead Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jon P. Stonehouse||Chief Executive Officer, President and Executive Director|
BioCryst Pharmaceuticals, Inc.
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|$3.6M||Compensation as of Fiscal Year 2014.|